Background: The androgen insensitivity syndrome may cause developmental failure of normal male external genitalia in individuals with 46,XY karyotype. It results from the diminished or absent biological action of androgens, which is mediated by the androgen receptor in both embryo and secondary sex development. Mutations in the androgen receptor gene, located on the X chromosome, are responsible for the disease. Almost 70% of 46,XY affected individuals inherited mutations from their carrier mothers. Findings. Molecular abnormalities in the androgen receptor gene in individuals of a Brazilian family with clinical features of severe forms of partial androgen insensitivity syndrome were evaluated. Seven members (five 46,XY females and two heal...
We report on a 17-year-old patient with midline defects, ocular hypertelorism, neuropsychomotor deve...
Background: Breast cancer (BC) is a genetic disorder characterized by growth and proliferation of br...
Dasatinib has demonstrated efficacy in patients with chronic-phase chronic myeloid leukemia (CML) wh...
Background: Disorders of sex development (DSD) is the term used for congenital conditions in which d...
The R337H TP53 mutation is a low-penetrance molecular defect that predisposes to adrenocortical tumo...
Secondary hormonal therapy is a treatment option in patients with castration-resistant prostate canc...
Disorders of sex development (DSD) involve several conditions that result from abnormalities during ...
Purpose. To understand the role of polymorphisms in the LEP (rs7799039 and rs2167270) and LEPR (rs11...
The aim was to characterize and correlate steroid hormone receptors with the FGF2, FGF7 and FGF8 rea...
Estrogen Receptor (ER) is an important target for pharmaceutical design. Like other ligand-dependent...
Individuals with Down syndrome (DS) carry three copies of the Cystathionine β-synthase (CβS) gene. T...
Objective To evaluate whether the single nucleotide polymorphism rs7895833 (A/G) of the gene SIRT1 i...
Tumor necrosis factor-α (TNF-α) is a potent inflammatory mediator with bone resorption activity. Pol...
Transforming growth factor-β1 is a multifunctional cytokine involved in extracellular matrix deposit...
Hormonal replacement has been utilized to minimize the harmful effects of hormonal imbalance in elde...
We report on a 17-year-old patient with midline defects, ocular hypertelorism, neuropsychomotor deve...
Background: Breast cancer (BC) is a genetic disorder characterized by growth and proliferation of br...
Dasatinib has demonstrated efficacy in patients with chronic-phase chronic myeloid leukemia (CML) wh...
Background: Disorders of sex development (DSD) is the term used for congenital conditions in which d...
The R337H TP53 mutation is a low-penetrance molecular defect that predisposes to adrenocortical tumo...
Secondary hormonal therapy is a treatment option in patients with castration-resistant prostate canc...
Disorders of sex development (DSD) involve several conditions that result from abnormalities during ...
Purpose. To understand the role of polymorphisms in the LEP (rs7799039 and rs2167270) and LEPR (rs11...
The aim was to characterize and correlate steroid hormone receptors with the FGF2, FGF7 and FGF8 rea...
Estrogen Receptor (ER) is an important target for pharmaceutical design. Like other ligand-dependent...
Individuals with Down syndrome (DS) carry three copies of the Cystathionine β-synthase (CβS) gene. T...
Objective To evaluate whether the single nucleotide polymorphism rs7895833 (A/G) of the gene SIRT1 i...
Tumor necrosis factor-α (TNF-α) is a potent inflammatory mediator with bone resorption activity. Pol...
Transforming growth factor-β1 is a multifunctional cytokine involved in extracellular matrix deposit...
Hormonal replacement has been utilized to minimize the harmful effects of hormonal imbalance in elde...
We report on a 17-year-old patient with midline defects, ocular hypertelorism, neuropsychomotor deve...
Background: Breast cancer (BC) is a genetic disorder characterized by growth and proliferation of br...
Dasatinib has demonstrated efficacy in patients with chronic-phase chronic myeloid leukemia (CML) wh...